These differences may reflect expectations as much as outcomes: Younger adults appear more sensitive to side effects, cost, or the friction of staying on treatment, while older adults may weigh benefits differently
Research use only (not for human or veterinary use) Every tissue within the body depends on an intricate network of cellular communication to maintain its structure, organisation and normal function
People taking GLP-1 medications had higher risks for 19 health outcomes, mostly involving digestive issues such as heartburn, nausea, vomiting, stomach pain and gastroparesis (stomach paralysis)
14 BurI
The art of tissue-specific and disease-specific dosing may emerge in the not-too-distant future: Rather than using the current pharmacologic doses of GLP-1s to soak receptors throughout the body, we may learn how to apply much more tailored brush strokes to effectively treat, say, dementia or rheumatoid arthritis
(2) The Human Evidence Gap No completed, peer-reviewed Phase II or Phase III randomized controlled trials in humans have been published as of July 2025